Pharmaceutical Technology

NOVEMBER 13, 2022

The US Food and Drug Administration (FDA) has granted approval for AstraZeneca ’s Imfinzi (durvalumab) plus Imjudo (tremelimumab) and platinum-based chemotherapy to treat Stage IV (metastatic) non-small cell lung cancer (NSCLC) in adults.

FDA 52

FDA Chemotherapy Labelling Immunization 52

pharmaphorum

JANUARY 26, 2022

Immunocore has secured a piece of biotech industry history, becoming the first company to get an FDA approval for a cancer therapeutic based on T cell receptor (TCR) technology. The post Immunocore claims first-ever FDA approval for TCR cancer therapy appeared first on.

FDA 121

FDA Chemotherapy Labelling Immunization 121

Pharmaceutical Technology

MARCH 6, 2023

Patients in the US and EU with recurrent or metastatic nasopharyngeal carcinoma (NPC), a subtype of head and neck squamous cell carcinoma (HNSCC), are mostly treated with a combination of chemotherapy agents in the frontline setting, such as cisplatin + gemcitabine. months for the chemotherapy arm (hazard ratio [HR]: 0.52).

Chemotherapy 52

Chemotherapy FDA Labelling Immunization 52

pharmaphorum

JANUARY 5, 2021

Roche’s closely-watched combination of two checkpoint inhibitors – TIGIT-targeting tiragolumab and PD-L1 drug Tecentriq – has claimed breakthrough status from the FDA. Roche’s drug is already FDA-approved as a monotherapy and in combination with Avastin (bevacizumab) and chemotherapy for previously-untreated NSCLC with high PD-L1 expression.

Chemotherapy 52

Chemotherapy Immunization FDA Labelling 52

The Checkup by Singlecare

AUGUST 11, 2023

These medications all tell immune system cells to produce more anti-inflammatory mediators and less inflammatory products. For instance, biologic agents, such as Enbrel and Humira, may have FDA indications for only a few of the uses of methylprednisolone. While it has many uses, Trexall also has its share of adverse effects.

Labelling 52

Labelling Immunization Dosage Chemotherapy 52

The Checkup by Singlecare

DECEMBER 13, 2023

Antihistamines work by blocking the effects of histamine , a chemical released by your body’s immune system. Antiemetics may also reduce radiation-associated or chemotherapy-induced nausea resulting from cancer treatment. Be sure to follow the dosing instructions on the label for your child’s age.

Dosage 97

Dosage Labelling Chemotherapy Immunization 97

European Pharmaceutical Review

OCTOBER 19, 2023

Granzyme B is an enzyme released by activated immune cells and using this as a in vivo imaging biomarker has great potential to monitor immune cell activation in a variety of inflammatory diseases, autoimmune diseases, cancer and infections. What do you envision the future of radiopharmaceuticals to be like?

Chemotherapy 86

Chemotherapy Compounding Immunization FDA 86